Unilateral intravitreal dexamethasone implant for the treatment of cystoid macular edema in intermediate uveitis

ABSTRACT This report aims to describe the effectiveness of a unilateral intravitreal dexamethasone implant (Ozurdex®) used for the treatment of cystoid macular edema in a patient with recurrent intermediate uveitis. Bearing in mind the adverse effects of the prolonged use of systemic corticosteroids, the objective here was to provide a less damaging form of intervention, and also to demonstrate the safety of the dexamethasone implant for patients who fail to respond to conventional treatment. In the present case, there was bilateral improvement in retinal anatomy and function with use of the unilateral intravitreal dexamethasone implant (Ozurdex®)..

Medienart:

E-Artikel

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

Zur Gesamtaufnahme - volume:80

Enthalten in:

Revista Brasileira de Oftalmologia - 80(2021), 2, Seite 140-142

Sprache:

Englisch ; Spanisch ; Portugiesisch

Beteiligte Personen:

Bruno Boalento dos Santos [VerfasserIn]
Maurélio de Lima Batista Ribeiro Jr [VerfasserIn]
Marcello Novoa Colombo Barboza [VerfasserIn]
Marta Fabiane Gouvea Barioni [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.scielo.br [kostenfrei]
Journal toc [kostenfrei]

Themen:

Cystoid macular edema
Dexamethasone
Intravitreal injections/adverse effects
Ophthalmology
Uveities, intermediate

doi:

10.5935/0034-7280.20210026

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ073469971